Browse by Research Team

Cancer Cell

Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
Bono, F., De Smet, F., Herbert, C., De Bock, K., Georgiadou, M., Fons, P., Tjwa, M., Alcouffe, C., Ny, A., Bianciotto, M., Jonckx, B., Murakami, M., Lanahan, A.A., Michielsen, C., Sibrac, D., Dol-Gleizes, F., Mazzone, M., Zacchigna, S., Herault, J.P., Fischer, C., Rigon, P., Ruiz de Almodovar, C., Claes, F., Blanc, I., Poesen, K., Zhang, J., Segura, I., Gueguen, G., Bordes, M.F., Lambrechts, D., Broussy, R., van de Wouwer, M., Michaux, C., Shimada, T., Jean, I., Blacher, S., Noel, A., Motte, P., Rom, E., Rakic, J.M., Katsuma, S., Schaeffer, P., Yayon, A., Van Schepdael, A., Schwalbe, H., Gervasio, F.L., Carmeliet, G., Rozensky, J., Dewerchin, M., Simons, M., Christopoulos, A., Herbert, J.M. and Carmeliet, P.
Cancer Cell 23 (4): 477-488. 15 April 2013

Cancer Research

Axon guidance factor Slit2 inhibits neural invasion and metastasis in pancreatic cancer.
Goehrig, A., Detjen, K.M., Hilfenhaus, G., Koerner, J., Welzel, M., Arsenic, R., Schmuck, R., Bahra, M., Wu, J.Y., Wiedenmann, B. and Fischer, C.
Cancer Research 74 (5): 1529-1540. 1 March 2014

Emerging Infectious Diseases

Human granulocytic anaplasmosis acquired in Scotland, 2013.
Hagedorn, P., Imhoff, M., Fischer, C., Domingo, C. and Niedrig, M.
Emerging Infectious Diseases 20 (6): 1079-1081. June 2014

Endocrine-Related Cancer

Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients.
Hilfenhaus, G., Goehrig, A., Pape, U.F., Neumann, T., Jann, H., Zdunek, D., Hess, G., Stassen, J.M., Wiedenmann, B., Detjen, K., Pavel, M. and Fischer, C.
Endocrine-Related Cancer 20 (3): 305-319. 20 May 2013

FASEB Journal

Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer.
Schulz, P., Fischer, C., Detjen, K.M., Rieke, S., Hilfenhaus, G., von Marschall, Z., Boehmig, M., Koch, I., Kehrberger, J., Hauff, P., Thierauch, K.H., Alves, F., Wiedenmann, B. and Scholz, A.
FASEB Journal 25 (10): 3325-3335. October 2011

Neoplasia

Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo.
Briest, F., Koziolek, E.J., Albrecht, J., Schmidt, F., Bernsen, M.R., Haeck, J., Kühl, A.A., Sedding, D., Hartung, T., Exner, S., Welzel, M., Fischer, C., Grötzinger, C., Brenner, W., Baum, R.P. and Grabowski, P.
Neoplasia 23 (1): 80-98. January 2021

Neuroendocrinology

Increased activity of the immunoregulatory enzyme indoleamine-2,3-dioxygenase (IDO) with consecutive tryptophan depletion predicts death in patients with neuroendocrine neoplasia.
Pschowski, R., Pape, U.F., Fusch, G., Fischer, C., Jann, H., Baur, A., Arsenic, R., Wiedenmann, B., von Haehling, S., Pavel, M. and Schefold, J.C.
Neuroendocrinology 104 (2): 135-144. December 2016

RoeFo Fortschritte auf dem Gebiete der Roentgenstrahlen und der neuen bildgebenden Verfahren

Morphological analysis and differentiation of benign cystic neoplasms of the pancreas using computed tomography and magnetic resonance imaging.
Grieser, C., Heine, G., Stelter, L., Steffen, I.G., Rothe, J.H., Walter, T.C., Fischer, C., Bahra, M. and Denecke, T.
RoeFo Fortschritte auf dem Gebiete der Roentgenstrahlen und der neuen bildgebenden Verfahren 185 (3): 219-227. March 2013